Vineet Laboratories cash flow

·Pharma & HealthChart ›
Latest FY26
Cash from operations
−₹12.2cr₹11.5 cr in FY25
Capital spending
₹1.2cr+14.5% on FY25
Free cash flow
−₹13.4cr₹10.4 cr in FY25
Cash from financing
₹29.7cr−₹8.2 cr in FY25
₹ crore except per share
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
Adjustments to reconcile profit — non-cash items
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
—2.42.5−0.02.4
—4.94.02.53.4
—−0.12.0−0.5−0.1
—0.0−0.0−0.00.0
—0.0−0.0−0.00.3
—0.00.00.00.2
Changes in working capital
—−14.1−0.6−3.2−2.6
—1.818.43.65.1
—−0.00.70.03.9
—0.00.0−0.10.0
—−2.83.2−1.5−0.3
—−0.0−0.50.1−0.1
—−8.31.4−2.6−26.3
—2.3−0.40.1−4.2
—0.40.00.00.0
—0.01.7−10.09.7
—−0.00.10.0−0.0
—0.00.00.20.0
Cash from operating activities
3.01.3−20.80.42.0
—−13.532.4−11.5−8.7
—−12.211.6−11.2−6.6
—0.00.10.33.0
—−12.211.5−11.4−9.6
Cash from investing activities
—1.21.00.27.6
—0.1−2.00.50.1
—−0.0−0.20.10.8
—−1.1−3.20.3−6.7
Cash from financing activities
—30.00.00.00.0
—−0.60.00.00.0
—10.2−3.619.14.6
—4.90.65.90.0
—4.94.02.53.4
—0.00.00.00.9
—29.7−8.210.70.3
—16.40.1−0.4−16.0
—16.40.1−0.4−16.0
———0.20.6
Reference items
10.48.5−16.37.27.7
16.7%14.3%−21.7%4.8%3.6%
−13.4−13.410.4−11.7−17.3
—−13.02.2−1.0—
−₹7.00−₹7.00₹5.44−₹6.07−₹8.98
—−7.63×−0.57×−11.13×−7.68×
—0.00.10.33.0
—4.94.02.53.4
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

VINEETLAB₹36.06

Vineet Laboratories Limited

· Pharma & Health
₹ CrorePeersBIOFILCHEMMANGALAMLASAKREBSBIOALPABALPHARMAORTINGLOBENATCAPSUQMcap ₹69.3 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation2.4-0.02.52.4—
+ Finance Costs3.42.54.04.9—
+ Interest Income-0.1-0.52.0-0.1—
+ Fair Value (Gains) / Losses0.0-0.0-0.00.0—
+ Unrealised FX (Gain) / Loss0.3-0.0-0.00.0—
+ Other Non-cash Items0.20.00.00.0—
Changes in Working Capital
+ Inventories-2.6-3.2-0.6-14.1—
+ Trade Receivables — Current5.13.618.41.8—
+ Other Financial Assets — Current3.90.00.7-0.0—
+ Other Financial Assets — Non-current0.0-0.10.00.0—
+ Other Current Assets-0.3-1.53.2-2.8—
+ Other Non-current Assets-0.10.1-0.5-0.0—
+ Trade Payables — Current-26.3-2.61.4-8.3—
+ Other Financial Liabilities — Current-4.20.1-0.42.3—
+ Other Financial Liabilities — Non-current0.00.00.00.4—
+ Other Current Liabilities9.7-10.01.70.0—
+ Provisions — Current-0.00.00.1-0.0—
+ Provisions — Non-current0.00.20.00.0—
Cash from Operating Activities
Profit Before Tax (per I/S)2.00.4-20.81.33.0
+ Total Adjustments (incl. Working Capital)-8.7-11.532.4-13.5—
Cash from Operations (pre-tax)-6.6-11.211.6-12.2—
+ Income Taxes Paid3.00.30.10.0—
Cash from Operating Activities-9.6-11.411.5-12.2—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)7.60.21.01.2—
+ Interest Received — Investing0.10.5-2.00.1—
+ Other Inflows / (Outflows) — Investing0.80.1-0.2-0.0—
Cash from Investing Activities-6.70.3-3.2-1.1—
Cash from Financing Activities
+ Proceeds from Issue of Shares0.00.00.030.0—
+ Proceeds from Other Equity Instruments0.00.00.0-0.6—
+ Proceeds from Borrowings4.619.1-3.610.2—
+ Repayment of Borrowings0.05.90.64.9—
+ Interest Paid3.42.54.04.9—
+ Dividends Paid0.90.00.00.0—
Cash from Financing Activities0.310.7-8.229.7—
Net Changes in Cash (pre-FX)-16.0-0.40.116.4—
Net Changes in Cash-16.0-0.40.116.4—
Closing Cash0.60.2———
Reference Items
EBITDA7.77.2-16.38.510.4
EBITDA Margin %3.614.78-21.7114.2716.70
Free Cash Flow (CFO − Capex)-17.3-11.710.4-13.4-13.4
Free Cash Flow to Equity—-1.02.2-13.0—
Free Cash Flow per Basic Share-8.98-6.075.44-7.00-7.00
Cash Flow to Net Income-7.68-11.13-0.57-7.63—
Cash Paid for Taxes3.00.30.10.0—
Cash Paid for Interest3.42.54.04.9—
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.